TILT and MSD working on immunotherapy trial for non-small cell lung cancer
TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has signed a second clinical trial…
September 26, 2022 - 3 minutes
Merck
Astellas, Seagen and Merck give details on urothelial cancer treatment
Astellas Pharma Inc., Seagen Inc. and Merck (known as MSD outside of the U.S. and…
September 12, 2022 - 5 minutes
Investment of €130M made by Merck’s MilliporeSigma for life-saving therapies
An investment of €130 million ($130 million) has been invested in Molsheim, France to strengthen…
September 8, 2022 - 2 minutes
CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded
Sigma-Aldrich Co LLC, along with genOway, a preclinical research model space company, announced today (September…
September 8, 2022 - 3 minutes
Merck puts up to $37B into Orna Therapeutics circular RNA collaboration
Merck, also known as MSD outside the U.S. and Canada, and Orna Therapeutics, a biotech…
August 16, 2022 - 3 minutes
Immutep reports positive data from cancer study
Immutep Limited, an Australian biotech company developing LAG-3-related immunotherapy treatments for cancer and autoimmune disease,…
August 1, 2022 - 4 minutes
BioMed X Institute and Merck start new oncology research project
BioMed X, a German independent research institute, has started a new research project ‘Extrachromosomal DNA…
August 1, 2022 - 3 minutes
Kelun-Biotech announces joint license agreement with MSD for drug targeting solid tumors
Kelun-Biotech and MSD (Merck & Co.) have announced they are entering in a joint license…
July 28, 2022 - 3 minutes
Sponsored
by Merck
You need to reach market readiness? What now?
Advancing a drug to market readiness is a major milestone. After successfully completing clinical studies,…
July 21, 2022 - 6 minutes
Global call for scientists and inventors to form new startup
A fourth start-up but the first of its kind sees some high-profile companies join forces…
June 29, 2022 - 3 minutes
Amphista Lands Megadeals to Smash Cancer using Protein Degradation
As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation…
May 5, 2022 - 3 minutes
Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer
The UK firm Artios Pharma raised a huge Series C round last week in one…
August 6, 2021 - 4 minutes
